semaglutide green bay Medical weight loss injections with GLP-1 Home - Dr. Gope Hotchandani
Description
Because GLP-1 receptor agonists are used to treat obesity and diabetes, and both obesity and diabetes are associated with an increased risk of pancreatitis, it can be difficult to determine whether the drug or the condition its treating is the cause
Combined with the Medicare GLP-1 Bridge ($50/month starting July 2026) and Novo Nordisks 70% price cuts, the market is consolidating around brand-name products
Diarrhea only occurs in about 8% of patients
Heart Health & Cardiovascular Protection Surprisingly, GLP-1 also supports heart health
Your response might be faster or slower
